Retroperitoneal robotic partial nephrectomy — why the approach matters

Robotic systems have reshaped kidney cancer surgery over the past decade. Yet one decision that remains consequential — and is less often discussed with patients — is which route the surgeon takes to reach the kidney. For selected patients and tumours, approaching from behind rather than through the front of the abdomen can mean faster gut recovery, a shorter operative pathway, and a smoother return home.

That route is the retroperitoneal approach, and it is the default in my practice for robotic partial nephrectomy. I am one of a small group of surgeons in Europe who use this as their standard technique, including for the most complex tumours.

The two routes to the kidney

Robotic partial nephrectomy can be performed through two principal approaches. The transperitoneal route enters through the main abdominal cavity — the surgeon navigates around or between loops of bowel to reach the kidney at the back. This is the more commonly taught approach and gives a wide field of view for large or anterior tumours.

The retroperitoneal route enters behind the peritoneal lining without opening the abdominal cavity at all. The surgeon accesses the kidney directly through the natural space between the peritoneum and the back body wall. The bowel is never entered, never handled, and never in the surgical field.

Both routes achieve the same oncological goals. The difference lies in what the patient experiences afterwards.

Why the retroperitoneal approach matters for recovery

The most practical benefit is bowel function. When the abdominal cavity is entered — even with the most careful technique — bowel handling causes a temporary ileus: a period of sluggish gut function that causes bloating, nausea, delayed return of appetite, and prolonged time before normal diet resumes. This is one of the main reasons patients feel unwell in hospital after abdominal surgery even when the procedure itself has gone perfectly.

With the retroperitoneal approach, the bowel is left completely undisturbed. Most patients resume normal diet within hours of surgery and report significantly less abdominal discomfort and bloating than they expected. The recovery pattern is closer to what you might expect after a minor procedure than a major cancer operation.

Other advantages include:

• Shorter path from skin to kidney — the renal vessels and tumour are reached more directly, which can reduce dissection and warm ischaemia time
• Particularly well suited to posterior and upper-pole tumours, which sit naturally in the retroperitoneal field of view
• Useful when a patient has had previous abdominal surgery, since adhesions within the peritoneal cavity are not encountered
• Reduced diaphragmatic irritation and associated shoulder-tip discomfort that can follow transperitoneal insufflation

Who is suitable for the retroperitoneal approach

The approach is not universally applicable and surgeon experience matters significantly — the retroperitoneal space is smaller and the anatomical landmarks are different from the transperitoneal approach. In experienced hands, however, the range of suitable patients is wide.

The retroperitoneal approach is particularly well suited when:

• The tumour sits posteriorly or posterolaterally on the kidney
• The patient has had previous abdominal operations with likely adhesions
• Central obesity increases bowel bulk in the transperitoneal space
• A solitary kidney requires the most direct and efficient vascular control
• The aim is the fastest possible return to eating and normal function

For very large anterior tumours requiring broad exposure, or where a concurrent abdominal procedure is planned, the transperitoneal route may be preferred. A surgeon experienced in both approaches can give an honest recommendation based on your specific anatomy and tumour characteristics.

Technical overview — the operation in brief

For those interested in the procedural detail, the operation follows a consistent structure. The patient is positioned on their side with the table flexed to open the space between the lower rib and the hip. A small incision below the tip of the 12th rib allows blunt dissection to the lumbodorsal fascia, and a working space is created behind the peritoneum. Three to four robotic ports and an assistant port are placed, triangulated around the kidney.

Key landmarks are the psoas muscle, ureter, gonadal vein, and renal hilum. The renal artery is identified early to allow selective clamping when needed. The tumour is excised with clear margins — either by enucleation along the pseudocapsule or by a wider resection for more aggressive-appearing lesions. The kidney is then repaired with layered sutures, with haemostatic agents used as needed for deeper defects.

Warm ischaemia — the period for which blood flow to the kidney is temporarily stopped — is targeted to the minimum practical time. For small exophytic lesions an off-clamp technique can often be used. My median warm ischaemia time in clamped cases runs in the 10–20 minute range.

Published evidence and outcomes

I published a series of retroperitoneal robotic partial nephrectomy as the default approach in the Journal of Robotic Surgery (2023), reporting outcomes including trifecta achievement rate, ischaemia times, and conversion rates across a series in which 48% of tumours were in the highest RENAL complexity category. This is not a selected low-risk series — it reflects real-world practice including tumours that other centres may have approached with radical nephrectomy.

The case for kidney-preserving surgery — partial rather than radical nephrectomy — is well established in the evidence base. Preserving nephrons protects long-term renal function, reduces cardiovascular risk downstream, and avoids the complications associated with chronic kidney disease. The retroperitoneal approach makes this preservation surgery faster, more direct, and more comfortable to recover from.

Questions to ask at your kidney cancer consultation

• Is my tumour suitable for partial nephrectomy, or is radical nephrectomy being recommended for anatomical reasons?
• Which approach — transperitoneal or retroperitoneal — would be used for my tumour, and why?
• What is the surgeon's personal trifecta rate and conversion rate for cases like mine?
• What is the expected warm ischaemia time, and what technique is planned for haemostasis?
• What is the follow-up plan for kidney function and oncological surveillance after surgery?